Kidney
Renal filtration/podocyte
Also searched as Renal filtration/podocyte.
You want it preserved: protecting renal function safeguards long-term metabolic and cardiovascular health.
In depth
Renal function — the kidney's capacity to filter blood and maintain fluid and mineral balance.
What drives it
Cell migration switch reduces it.
Lovisa 2015, Nat Med 21:998 — tubular epithelial cells undergo a partial EMT program in renal fibrosis, arresting in G2 and downregulating solute transporters, causing parenchymal damage and loss of renal function. PMID 26236991
Lowers uric acid reduces it.
Urate-lowering/CKD review — hyperuricemia is an independent risk factor for CKD progression (urate-driven oxidative stress, endothelial injury, crystal deposition); lowering serum urate attenuates renal decline. PMC6131097
Reduces sugar damage reduces it.
10.1155/2016/1802036 — Nutrients 2025 review — AGE accumulation and the AGE/RAGE axis drive diabetic nephropathy and CKD progression via oxidative stress and inflammation. doi 10.1155/2016/1802036
Cardiac output increases it.
Cardiorenal syndrome - the two organs fail together and each accelerates the other. The reverse arm is at least as well documented and is not drawn: hypertension is the second most frequent cause of chronic kidney disease. Drawing only heart-to-kidney shows half of a two-way relationship. doi 10.1016/j.jacc.2006.07.007 · PMC10932393
Heart & blood pressure increases it.
The hallmarks literature describes what drives aging and what aging drives, in the same reviews. Named across five inflammaging and hallmarks-of-aging reviews. The systemic inflammation stemming from dysbiosis adversely affects multiple organ systems, and the reviews trace increased frailty, diminished physical capacity, cognitive impairment, and elevated mortality risk as the shared downstream set. doi 10.1016/j.molmet.2023.101755 · PMC11233824
Insulin sensitivity increases it.
The reviewers say this has been missed: the impact of insulin resistance and compensatory hyperinsulinemia on kidney function, and their contribution to CKD, have largely been overlooked in people with OR without diabetes. And the kidney is an insulin target organ in its own right: beyond its classical metabolic targets - muscle, liver and adipocytes - insulin has an essential role in kidney metabolism and physiology, regulating podocyte integrity, tubular sodium handling and gluconeogenesis. In resistance these are disrupted, leading to glomerular hyperfiltration, proteinuria, sodium retention, progressive kidney injury. doi 10.1038/s41581-026-01066-0 · PMC11725408
Fasting insulin reduces it.
Chronic hyperinsulinemia activates pro-growth and pro-fibrotic pathways, resulting in vascular dysfunction, inflammation and fibrosis. This is the insulin level doing damage, separately from the resistance - which is why fasting insulin exists as a node distinct from insulin, and this edge is the clearest case for that split anywhere on the map. doi 10.1038/s41581-026-01066-0 · PMC11725408
Lowers cholesterol increases it.
Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. doi 10.1038/s41581-026-01066-0 · PMC11725408
Oxidative stress reduces it.
Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. (doi 10.1038/s41581-026-01066-0; doi 10.3390/ijms26146962; PMC11725408; PMC11906131; PMC11764088; PMC12257864). Verbatim: “Oxidative stress plays a role in initiating acute kidney injury by activating the pro-apoptotic pathways, eventually leading to cell death and releasing chemokines and cytokines, further exacerbating the injury by recruiting the immune cells”. doi 10.1038/s41581-026-01066-0 · PMID 41074478 · PMC11725408
Calms body-wide inflammation reduces it.
heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. doi 10.1038/s41581-026-01066-0 · PMC11725408
Calms inflammation reduces it.
Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. doi 10.1038/s41581-026-01066-0 · PMC11725408
Supports weight management reduces it.
Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. doi 10.1038/s41581-026-01066-0 · PMC11725408
Gut barrier increases it.
Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. doi 10.1038/s41581-026-01066-0 · PMC11725408
Lowers blood pressure reduces it.
Named across five reviews of the cardiovascular-renal-hepatic-metabolic syndrome as part of the shared mechanism set: ectopic fat accumulation triggered by metabolic reprogramming, oxidative stress and inflammation induced by energy overload, modified lipids, UREMIC toxins, and senescence, as well as insulin resistance pathways activated by pro-inflammatory factors and lipotoxic products, collectively exacerbate simultaneous hepatic and renal injury. doi 10.1038/s41581-026-01066-0 · PMC11725408
What it drives
It increases Cardiac output.
The the Contractility → Renal Function link note said the reverse arm is at least as well documented and is not drawn - hypertension is the second most frequent cause of chronic kidney disease, and renal disease drives volume overload, anemia and mineral-bone disease that load the heart. With one arrow the MAP said the heart damages the kidney. With both it says they fail together and each accelerates the other - which is why treating one in isolation disappoints, and why cardiorenal syndrome has its own name. PMC10253706
It increases Sexual function.
Named across six reviews of endothelial dysfunction as part of the shared mechanism set: reduced nitric oxide availability, oxidative stress, inflammatory responses, apoptosis of endothelial cells, and the emerging concept of endothelial-mesenchymal transition. doi 10.3390/jcm15041621 · PMID 33923709 · PMC11988752
It reduces Nerve protection.
Named across six reviews of endothelial dysfunction as part of the shared mechanism set: reduced nitric oxide availability, oxidative stress, inflammatory responses, apoptosis of endothelial cells, and the emerging concept of endothelial-mesenchymal transition. doi 10.3390/jcm15041621 · PMID 33923709 · PMC11988752
It increases Strengthens veins.
Named across six reviews of endothelial dysfunction as part of the shared mechanism set: reduced nitric oxide availability, oxidative stress, inflammatory responses, apoptosis of endothelial cells, and the emerging concept of endothelial-mesenchymal transition. doi 10.3390/jcm15041621 · PMID 33923709 · PMC11988752
It reduces Urate clearance.
The architecture is unusually clean and worth stating: gout has two separable stages. Stage one is metabolic - urate underexcretion through renal and gut mechanisms is the major mechanism for hyperuricemia in most people, via URAT1, GLUT9 and ABCG2. Stage two is immunological - MSU crystals function as damage-associated molecular patterns which, upon phagocytosis by macrophages, activate the NLRP3 inflammasome through a two-step process: priming via NF-kB signaling and activation via lysosomal rupture, potassium efflux, and mitochondrial ROS. And the two stages come apart in people: not all individuals with hyperuricemia show deposition of MSU crystals OR develop gout. Local factors decide - reduced joint temperature, low pH, high sodium concentration, and preexisting joint damage. A urate number is not a diagnosis. The treatment target is explicit: long-term lowering of serum urate to less than 360 MICROMOL/L leads to crystal dissolution and ultimately to suppression of flares. PMID 39712248 · PMC8268734
It increases Micronutrient status.
10.3390/biomedicines12040911 — Micronutrient status is assembled from supplement-trial indices; none of the papers cited studied micronutrient status itself. doi 10.3390/biomedicines12040911
It increases Blood pressure hormone.
NBK470410 — Renin is secreted by the juxtaglomerular apparatus; renal perfusion sets its release.
It increases Vitamin D status.
10.1038/s41598-022-15033-9 — Drawn from the reviews of this outcome. doi 10.1038/s41598-022-15033-9
It increases Iron & oxygen carriage.
The mechanism that makes iron supplementation fail: anemia of inflammation is characterized by the insufficient production of erythropoietin and decreased response of erythroid progenitors to EPO. In addition, it inhibits the release of iron from the body stores and alters the iron status after being stimulated by hepcidin. Inflammation locks iron away - so oral iron given into an inflammatory state does not reach the marrow. Anemia affects 1.62 billion people. And the periodontal link is measured: a meta-analysis of sixteen studies on hemoglobin and iron metabolism in periodontitis - though the authors call the association still controversial and ask for larger cohorts. PMID 835510 · PMC7005133
It increases Liver clearance.
10.1016/j.csbj.2025.11.039 — https://www.merckmanuals.com/professional/clinical-pharmacology/pharmacokinetics/drug-excretion — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). doi 10.1016/j.csbj.2025.11.039
It increases Thyroid.
PMC4009121 — This link rests on the reviews of this outcome as a whole. No effect size specific to this arm has been reported, so it is shown at reduced weight. (from the reviews of this outcome). PMC4009121
It increases Hydration & electrolytes.
Renal handling sets sodium, potassium and water balance. PMC7005133
It increases Carnitine shuttle.
The kidney both synthesizes and reabsorbs carnitine; renal impairment alters status. Carried by the intermediary-metabolism reviews. doi 10.1016/j.molmet.2023.101755 · PMC9967593
Blends that modulate it
Each blend page names this pathway and carries the study behind its claim.
See it on the map
Open the causal map to follow this pathway upstream and downstream, arrow by arrow, each with its study.